CD8A and neoplasm: As expected, the reduction in PD-L1 expression in KEAP1-overexpressing cells led to an upregulation of tumor immunity, evidenced by elevated levels of total and activated CD8+ cytotoxic T cells (GzmB+) within tumor-infiltrating lymphocytes (Fig. 6H, I and Figure S3B).